Molecular Omics

杂志介绍

Molecular Omics杂志介绍

《Molecular Omics》是一本以English为主的未开放获取国际优秀期刊，中文名称分子组学，本刊主要出版、报道生物-生化与分子生物学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.273，最新CiteScore 指数为4.9。

本刊近期中国学者发表的论文主要有：

• Lamiophlomis rotata attenuates rheumatoid arthritis by regulating sphingolipid and steroid hormone metabolis

  Author:

• The landscape of N6-methyladenosine modification patterns and altered transcript profiles in the cardiac-specific deletion of natriuretic peptide receptor

  Author:

• Identification of potential biomarkers for diagnosis of syphilis from the cerebrospinal fluid based on untargeted metabolomic analysi

  Author:

• Geographical origin traceability of rice using a FTIR-based metabolomics approac

  Author:

英文介绍

Molecular Omics杂志英文介绍

Molecular Omics publishes high-quality research from across the -omics sciences.

Topics include, but are not limited to:

-omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance

-omics studies for clinical applications with validation, such as finding biomarkers for diagnostics or potential new drug targets

-omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques

-studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field.

Molecular Omics only accepts articles of high importance and interest that provide significant new insight into important chemical or biological problems. This could be fundamental research that significantly increases understanding or research that demonstrates clear functional benefits.

Papers reporting new results that could be routinely predicted, do not show a significant improvement over known research, or are of interest only to the specialist in the area are not suitable for publication in Molecular Omics.